Geoffrey Ling M.D., Director at CATALYST BIOSCIENCES, INC. (CBIO), bought 3,000 shares at $6.23 ($19K) on 2020-02-25, disclosed to the SEC on 2020-02-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.